-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RZ57EnT9t+Z6GVH0IMgefg2iYcqdkqYiuHXtw6f3S09BwFPBVIQdStZS3UXJ4CG9 LO5Tsz51dWwmzPwk4Q3UoA== 0000914121-03-000431.txt : 20030416 0000914121-03-000431.hdr.sgml : 20030416 20030416092531 ACCESSION NUMBER: 0000914121-03-000431 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030416 EFFECTIVENESS DATE: 20030416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-02516 FILM NUMBER: 03651721 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 15-12B 1 pf666302_rw.txt NOTICE OF TERMINATION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------------- FORM 15 -------------------- Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number: 001-02516 PHARMACIA CORPORATION - ------------------------------------------------------------------------------ (Exact name of registrant as specified in its charter) 100 Route 206 North Peapack, NJ 07977 (908) 901-8000 - ------------------------------------------------------------------------------ (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Common Stock, par value $2.00 per share Rights to Purchase Preferred Stock - ------------------------------------------------------------------------------ (Title of each class of securities covered by this Form) None - ------------------------------------------------------------------------------ (Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4 (a)(1)(i) [X ] Rule 12h-3 (b)(1)(ii) [ ] Rule 12g-4 (a)(1)(ii) [ ] Rule 12h-3 (b)(2)(i) [ ] Rule 12g-4 (a)(2)(i) [ ] Rule 12h-3 (b)(2)(ii) [ ] Rule 12g-4 (a)(2)(ii) [ ] Rule 15d-6 [ ] Rule 12h-3 (b)(1)(i) [X ] Approximate number of holders of record as of the certification or notice date: 1 Pursuant to the requirements of the Securities Exchange Act of 1934, Pharmacia Corporation, a Delaware corporation, by the undersigned duly authorized person. Dated: April 16, 2003 PHARMACIA CORPORATION By: /s/ Don W. Schmitz ------------------------------------ Name: Don W. Schmitz Title: Corporate Secretary -----END PRIVACY-ENHANCED MESSAGE-----